fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CHMP recommends Artesunate Amivas for the initial treatment of severe malaria – Amivas

Written by | 13 Oct 2021

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Artesunate Amivas, intended for… read more.

Ebola Vaccine Regimen demonstrated robust and durable immune response in adults and children in data published in The Lancet Infectious Diseases – Johnson & Johnson

Written by | 7 Oct 2021

Data from two papers published in The Lancet Infectious Diseases demonstrated that the Johnson & Johnson (the Company) Ebola vaccine regimen, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo), generated robust… read more.

Johnson & Johnson announces real-world evidence and phase III data confirming strong and long-lasting protection of single-shot COVID-19 vaccine in the U.S.

Written by | 3 Oct 2021

Johnson & Johnson announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine . New data also showed that protection against COVID-19 increases when a… read more.

New findings on ambient UVB radiation, vitamin D, and protection against severe COVID-19

Written by | 1 Oct 2021

New research from Trinity College Dublin and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which… read more.

Analyses published in NEJM of a third booster shot of the Comirnaty messenger RNA vaccine from Pfizer

Written by | 19 Sep 2021

Publication of two separate analyses in The New England Journal of Medicine comes before a meeting of FDA advisers to discuss Pfizer’s application for authorization of a third… read more.

EU approval boosts COVID vaccine manufacturing capacity

Written by | 5 Sep 2021

The European Medicines Agency (EMA) has approved additional manufacturing capacity for the Pfizer/BioNTech COVID-19 vaccine in France – increasing production by 51 million doses by the end of… read more.

Saphnelo approved in the US for moderate to severe systemic lupus erythematosus – AstraZeneca

Written by | 10 Aug 2021

AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy…. read more.

Vitamin C essential for immune cell function

Written by | 4 Aug 2021

Investigations carried out at the La Jolla institute for Immunology (LJI) Show that the combination of vitamin C and TET proteins are essential for the proper function of… read more.

Phase III HELP study of Takhzyro shows long-term safety and efficacy in Hereditary Angioedema – Takeda

Written by | 25 Jul 2021

Takeda Pharmaceutical announced results from two final analyses from the Phase III HELP (Hereditary Angioedema Long-term Prophylaxis) Study Open-label Extension (OLE), which evaluated the long-term safety (primary endpoint)… read more.

Young male students at the centre of HIV surge

Written by | 20 Jul 2021

There has been a rapid rise in the number of human immunodeficiency virus (HIV) infections in China since the dawn of the 21st century. In the recent past,… read more.

Immunologists discover ‘spider web’ mechanism that traps viruses

Written by | 19 Jul 2021

Scientists at McMaster University in Toronto have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the… read more.

Metabolic hormone ‘leptin’ linked to poor vaccine response

Written by | 15 Jun 2021

Reduced levels of a metabolic hormone known as leptin is linked to poor vaccine antibody responses in the general population, a University of Queensland study has found. The… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.